External
Join Sidley and industry leaders from across the globe, including from AstraZeneca, BioCentury, Compass Pathways, Flagship Pioneering, IQVIA, LetterOne Health, Microsoft, Mestag Therapeutics, Morgan Stanley, Novartis, Permira, Perspectum, Rothschild & Co., Sofinnova Partners, Syncona, SV Health Investors, and Teva for this in-person, all-day event. Virtual attendance is available to those outside the UK.
VIEW THE AGENDA AND CONFIRMED SPEAKERS
Panels will include:
- Fireside Chat – “A Life in Pharma and Pivoting to Innovation” - A conversation with Richard Francis, President and CEO, Teva.
- Pharma Business Development – Senior BD and biotech figures debate the M&A, licensing, and collaboration climate. Which therapeutic areas and geographies are garnering the most attention.
- Private Equity – What is the outlook for PE investment activity across Healthcare and Life Sciences? Which domains will be the “winners”?
- Artificial Intelligence – To what extent, and where, does AI represent an investment opportunity across Healthcare and Life Sciences?
- A View From the Banks – Opinions, insights, and predictions on the market from a group of leading global healthcare dealmakers.
- Venture/Growth Capital – How are global funds investing in a more muted market? How do investees stand out? Views from leading global life sciences investors.
Please note that spaces for this event are limited.
